It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Single-stranded circular RNAs (circRNAs), generated through ‘backsplicing’, occur more extensively than initially anticipated. The possible functions of the vast majority of circRNAs remain unknown. Virus-derived circRNAs have recently been described in gamma-herpesviruses. We report that oncogenic human papillomaviruses (HPVs) generate circRNAs, some of which encompass the E7 oncogene (circE7). HPV16 circE7 is detectable by both inverse RT-PCR and northern blotting of HPV16-transformed cells. CircE7 is N6-methyladenosine (m6A) modified, preferentially localized to the cytoplasm, associated with polysomes, and translated to produce E7 oncoprotein. Specific disruption of circE7 in CaSki cervical carcinoma cells reduces E7 protein levels and inhibits cancer cell growth both in vitro and in tumor xenografts. CircE7 is present in TCGA RNA-Seq data from HPV-positive cancers and in cell lines with only episomal HPVs. These results provide evidence that virus-derived, protein-encoding circular RNAs are biologically functional and linked to the transforming properties of some HPV.
The authors identify circular RNAs (circRNA) from human papillomavirus and show that circRNA-encoded E7 contributes to cancer cell growth in vitro and in tumor xenografts. Furthermore, circE7 is present in TCGA RNA-Seq data from HPV-positive cancers.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 UT Southwestern Medical Center, Department of Dermatology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)
2 UT Southwestern Medical Center, Quantitative Biomedical Research Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)
3 UT Southwestern Medical Center, Department of Molecular Biology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)
4 Northwestern University, Department of Microbiology-Immunology, Feinberg School of Medicine, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
5 UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); UT Southwestern Medical Center, Department of Biochemistry, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); UT Southwestern Medical Center, Department of Pharmacology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)
6 UT Southwestern Medical Center, Department of Dermatology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); UT Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)